• <nav id="uiwcm"><strong id="uiwcm"></strong></nav>
  • <menu id="uiwcm"></menu>

    —— 行業資訊 ——


    發布時間:2021-12-06 /} 瀏覽次:數

            Among the elements of preparation generic development, the bottleneck of domestic preparation enterprises is the limitation of excipients. In the volume IV of the Chinese Pharmacopoeia (2020 edition), the number of excipients has increased from 76 in 2005 to 335 at present, increased for 5 times. The application in preparation is the ultimate purpose of excipients, and the improvement of excipients performance is also beneficial to the guarantee of the quality of preparation. In recent years, a number of high-quality excipients manufacturers with advanced technology and large scale have emerged in China. The Excipients manufacturing quality group will invite these enterprises to introduce some of their achievements related to preparation R&D. At 9:00AM this Saturday (2021.12.11), the enterprises Anhui Sunhere Pharmaceutical Excipients Co., Ltd and Xi'an DELI Biochemical Industry Co., Ltd. will talk about the performance and parameter comparison of microcrystalline cellulose, beta cyclodextrin and its derivatives. Please join in to watch online and discuss.

    上一篇 : 國家藥監局藥審中心關于發布《化學藥品注射劑仿制藥質量和療效一

    下一篇 : 輔料定制專題:目前輔料企業的做法

    18禁纯肉高黄无码动漫-特黄a级毛片-激情文学小说区另类小说 <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <文本链> <文本链> <文本链> <文本链> <文本链> <文本链>